181 related articles for article (PubMed ID: 16131457)
1. Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade.
Wang J; Weil MH; Tang W; Sun S; Huang L
J Lab Clin Med; 2005 Sep; 146(3):179-83. PubMed ID: 16131457
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
[TBL] [Abstract][Full Text] [Related]
3. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation.
Pellis T; Weil MH; Tang W; Sun S; Xie J; Song L; Checchia P
Circulation; 2003 Nov; 108(21):2716-21. PubMed ID: 14623815
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Leppikangas H; Ruokonen E; Rutanen J; Kiviniemi V; Lindgren L; Kurola J
Ann Emerg Med; 2009 Dec; 54(6):811-817.e1-3. PubMed ID: 19766354
[TBL] [Abstract][Full Text] [Related]
5. Combination pharmacotherapy in the treatment of experimental cardiac arrest.
Xanthos T; Bassiakou E; Koudouna E; Rokas G; Goulas S; Dontas I; Kouskouni E; Perrea D; Papadimitriou L
Am J Emerg Med; 2009 Jul; 27(6):651-9. PubMed ID: 19751621
[TBL] [Abstract][Full Text] [Related]
6. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Huang L; Weil MH; Tang W; Sun S; Wang J
Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest.
Koudouna E; Xanthos T; Bassiakou E; Goulas S; Lelovas P; Papadimitriou D; Tsirikos N; Papadimitriou L
Acta Anaesthesiol Scand; 2007 Sep; 51(8):1123-9. PubMed ID: 17697310
[TBL] [Abstract][Full Text] [Related]
8. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats.
Kelm RF; Wagenführer J; Bauer H; Schmidtmann I; Engelhard K; Noppens RR
Crit Care Med; 2014 Jun; 42(6):e410-9. PubMed ID: 24633188
[TBL] [Abstract][Full Text] [Related]
9. Mechanism by which activation of delta-opioid receptor reduces the severity of postresuscitation myocardial dysfunction.
Fang X; Tang W; Sun S; Huang L; Huang Z; Weil MH
Crit Care Med; 2006 Oct; 34(10):2607-12. PubMed ID: 16775573
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous blockade of alpha1- and beta-actions of epinephrine during cardiopulmonary resuscitation.
Huang L; Sun S; Fang X; Tang W; Weil MH
Crit Care Med; 2006 Dec; 34(12 Suppl):S483-5. PubMed ID: 17114981
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens.
Kalam Y; Graudins A
Int J Toxicol; 2012 Mar; 31(2):166-74. PubMed ID: 22422349
[TBL] [Abstract][Full Text] [Related]
12. Epinephrine increases the severity of postresuscitation myocardial dysfunction.
Tang W; Weil MH; Sun S; Noc M; Yang L; Gazmuri RJ
Circulation; 1995 Nov; 92(10):3089-93. PubMed ID: 7586280
[TBL] [Abstract][Full Text] [Related]
13. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
14. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
15. Minimal interruption of cardiopulmonary resuscitation for a single shock as mandated by automated external defibrillations does not compromise outcomes in a porcine model of cardiac arrest and resuscitation.
Ristagno G; Tang W; Russell JK; Jorgenson D; Wang H; Sun S; Weil MH
Crit Care Med; 2008 Nov; 36(11):3048-53. PubMed ID: 18824916
[TBL] [Abstract][Full Text] [Related]
16. Influence of dobutamine on the variables of systemic haemodynamics, metabolism, and intestinal perfusion after cardiopulmonary resuscitation in the rat.
Studer W; Wu X; Siegemund M; Marsch S; Seeberger M; Filipovic M
Resuscitation; 2005 Feb; 64(2):227-32. PubMed ID: 15680534
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan.
Müller S; How OJ; Jakobsen Ø; Hermansen SE; Røsner A; Stenberg TA; Myrmel T
Circ Heart Fail; 2010 Mar; 3(2):277-85. PubMed ID: 20018954
[TBL] [Abstract][Full Text] [Related]
18. Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation.
Bassiakou E; Xanthos T; Koudouna E; Goulas S; Prapa V; Papadimitriou D; Rokas G; Papadimitriou L
Am J Emerg Med; 2008 Jun; 26(5):578-84. PubMed ID: 18534288
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
20. A selective alpha(2)-adrenergic agonist for cardiac resuscitation.
Klouche K; Weil MH; Tang W; Povoas H; Kamohara T; Bisera J
J Lab Clin Med; 2002 Jul; 140(1):27-34. PubMed ID: 12080325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
